BECN1 and amyotrophic lateral sclerosis: In comparison with the control cells, the expression level of beclin 1 was increased 1.6- and 1.9-fold with the treatment of ALS at 1 and 5 μM, respectively, and the level of LC3-II was increased after ALS treatment in HT29 cells.